nsc 3852 has been researched along with chiniofon in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gannett, P; Griffith, B; Leonard, S; Martirosyan, A; Shi, X; Strobl, J | 1 |
Li, Y; Lindsay, DS; Mitchell, SM; Nagarkatti, R; Rathore, D; Rosypal, AC; Seibert, CW; Strobl, JS | 1 |
Bartels, M; Coffer, PJ; Egan, DA; Govers, AMAP; Lelieveld, D; Sonneveld, E; Wiggers, CRM; Zwaan, CM | 1 |
3 other study(ies) available for nsc 3852 and chiniofon
Article | Year |
---|---|
Actions of a histone deacetylase inhibitor NSC3852 (5-nitroso-8-quinolinol) link reactive oxygen species to cell differentiation and apoptosis in MCF-7 human mammary tumor cells.
Topics: Apoptosis; Breast Neoplasms; Cell Differentiation; Cell Line, Tumor; DNA Damage; Dose-Response Relationship, Drug; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Glutathione; Histone Deacetylase Inhibitors; Humans; Hydroxyquinolines; Nitroso Compounds; Reactive Oxygen Species | 2006 |
Inhibition of Toxoplasma gondii and Plasmodium falciparum infections in vitro by NSC3852, a redox active antiproliferative and tumor cell differentiation agent.
Topics: Animals; Antineoplastic Agents; Antioxidants; Antiprotozoal Agents; Benzothiazoles; Cell Line; Cells, Cultured; Diamines; Erythrocytes; Fibroblasts; Fluorescent Dyes; Humans; Hydroxyquinolines; Nitric Oxide; Nitroso Compounds; Organic Chemicals; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Reactive Oxygen Species; Toxoplasma | 2009 |
Epigenetic drug screen identifies the histone deacetylase inhibitor NSC3852 as a potential novel drug for the treatment of pediatric acute myeloid leukemia.
Topics: Apoptosis; Cell Proliferation; Child; Down Syndrome; Drug Screening Assays, Antitumor; Epigenesis, Genetic; High-Throughput Screening Assays; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxyquinolines; Leukemia, Megakaryoblastic, Acute; Leukemia, Myeloid, Acute; Leukemoid Reaction; Nitroso Compounds; Prognosis; Tumor Cells, Cultured | 2019 |